Hizentra (subcutaneous immunoglobulin)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Hizentra (subcutaneous immunoglobulin), covering 2013-03-20 to 2013-03-20. Get the full timeline:
Most recent: Clinical Trial Update: Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study) [Phase 3]